Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-011756

President and CEO sold 27,750 shares at an average $31.11 ($863,378)

From the SEC's structured data for this filing

Trades in this filing

SCANGOS GEORGE A · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-17 Sale : show line 1 in the form −10,024 $31.93 $320,074 130,715 D
2022-02-18 Sale : show line 2 in the form −17,726 $30.65 $543,304 112,989 D
Open-market sales · 27,750 sh · avg $31.11 · $863,378
Loading xslF345X03/doc4.xml…